Drug recall · October 21, 2015
Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution recall
Why: Lack of Assurance of Sterility; potential exposure to non-sterile lubricant during the filling process
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution, packaged in 30x3 mL Sterile Unit-Dose Vials, a) 30 count (NDC 0487-0201-03) and b) 60 count (NDC 0487-0201-60) vials per carton, Rx only, Nephron Pharmaceutical Corporation, Orlando, FL
- Lots / codes
a) Lot D4E20A, exp 3/2016 and b) Lot D4C21A, exp 3/2016
- Quantity
- a) 85,248 cartons and b) 35,292 cartons
- Company
- Nephron Pharmaceuticals Corp., Orlando, FL
- Distribution
- Nationwide
- Initiated
- August 21, 2015 · Voluntary: Firm initiated
- Classified
- October 9, 2015
- Reported
- October 21, 2015
- Ended
- February 10, 2017
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Albuterol / ipratropium
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.